Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Sichuan Hebang Biotechnology Corporation Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥1.65 |
52 Week High | CN¥2.70 |
52 Week Low | CN¥1.63 |
Beta | 0.32 |
11 Month Change | -14.95% |
3 Month Change | -30.08% |
1 Year Change | -31.25% |
33 Year Change | -18.32% |
5 Year Change | -16.67% |
Change since IPO | -4.22% |
Recent News & Updates
Recent updates
Shareholder Returns
603077 | CN Chemicals | CN Market | |
---|---|---|---|
7D | -0.6% | -1.7% | -1.4% |
1Y | -31.3% | -24.3% | -19.1% |
Return vs Industry: 603077 underperformed the CN Chemicals industry which returned -24.3% over the past year.
Return vs Market: 603077 underperformed the CN Market which returned -19.1% over the past year.
Price Volatility
603077 volatility | |
---|---|
603077 Average Weekly Movement | 5.1% |
Chemicals Industry Average Movement | 6.9% |
Market Average Movement | 6.6% |
10% most volatile stocks in CN Market | 10.0% |
10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 603077's share price has been volatile over the past 3 months.
Volatility Over Time: 603077's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2002 | 7,169 | Xiaoping Zeng | www.hebang.cn |
Sichuan Hebang Biotechnology Corporation Limited provides agricultural, chemical, and new material products. It offers biological pesticides, biological veterinary drugs, and methionine products; and sodium carbonate, ammonium chloride, soda ash, diglyphosate, glyphosate, and brine. The company also provides original glass and smart glass, special glass, low-e coated glass, and photovoltaic packaging materials and products, as well as photovoltaic glass and module products.
Sichuan Hebang Biotechnology Corporation Limited Fundamentals Summary
603077 fundamental statistics | |
---|---|
Market cap | CN¥13.63b |
Earnings (TTM) | CN¥916.48m |
Revenue (TTM) | CN¥8.43b |
14.9x
P/E Ratio1.6x
P/S RatioIs 603077 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
603077 income statement (TTM) | |
---|---|
Revenue | CN¥8.43b |
Cost of Revenue | CN¥6.85b |
Gross Profit | CN¥1.58b |
Other Expenses | CN¥661.40m |
Earnings | CN¥916.48m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 30, 2024
Earnings per share (EPS) | 0.11 |
Gross Margin | 18.72% |
Net Profit Margin | 10.87% |
Debt/Equity Ratio | 15.0% |
How did 603077 perform over the long term?
See historical performance and comparison